Last $54.38 USD
Change Today -0.36 / -0.66%
Volume 1.6M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
SIX Swiss Ex
EN Paris
As of 11:06 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for eli lilly & co (LLY)

Year over year, Eli Lilly and Company has seen revenues fall from $24.3B USD to $22.6B USD. In addition, the company has been unable to reduce the percentage of sales devoted to cost of goods sold, SGA expenses and income tax expenses. This has led to a reduction in the bottom line from $4.3B USD to $4.1B USD.
Currency in
Millions of US Dollars
As of:Dec 31
2009
Dec 31
2010
Reclassified
Dec 31
2011
Dec 31
2012
4 Year
Trend
Revenues21,836.023,076.024,286.522,603.4
TOTAL REVENUES21,836.023,076.024,286.522,603.4
Cost of Goods Sold4,247.04,366.25,067.94,796.5
GROSS PROFIT17,589.018,709.819,218.617,806.9
Selling General & Admin Expenses, Total6,892.57,053.47,879.97,513.5
R&D Expenses4,326.54,884.25,020.85,278.1
OTHER OPERATING EXPENSES, TOTAL11,219.011,937.612,900.712,791.6
OPERATING INCOME6,370.06,772.26,317.95,015.3
Interest Expense-261.3-185.5-186.0-177.8
Interest and Investment Income75.251.979.9105.0
Other Non-Operating Expenses, Total-105.522.7-51.5-112.4
Other Non-Operating Income (Expenses)-22.934.745.9-148.2
Merger & Restructuring Charges-99.0-142.0-316.4-74.5
Gain (Loss) on Sale of Investments62.1105.9130.171.4
Other Unusual Items, Total-683.7-100.0-624.5581.2
EBT, INCLUDING UNUSUAL ITEMS5,357.86,525.25,349.55,408.2
Income Tax Expense1,029.01,455.71,001.81,319.6
Earnings from Continuing Operations4,328.85,069.54,347.74,088.6
NET INCOME4,328.85,069.54,347.74,088.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4,328.85,069.54,347.74,088.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4,328.85,069.54,347.74,088.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $54.29 USD -0.45

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $45.73 USD -0.86
Amgen Inc $105.64 USD +0.021
AstraZeneca PLC 3,429 GBp +2.50
Bristol-Myers Squibb Co $46.78 USD -0.22
Novo Nordisk A/S kr967.50 DKK -1.50
View Industry Companies
 

Industry Analysis

LLY

Industry Average

Valuation LLY Industry Range
Price/Earnings 13.1x
Price/Sales 2.6x
Price/Book 4.0x
Price/Cash Flow 13.3x
TEV/Sales 2.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.